BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//KESHO - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KESHO
X-ORIGINAL-URL:https://kesho-kenya.org
X-WR-CALDESC:Events for KESHO
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240808T190000
DTEND;TZID=Africa/Nairobi:20240808T203000
DTSTAMP:20260424T005615
CREATED:20240704T122842Z
LAST-MODIFIED:20250622T144126Z
UID:9879-1723143600-1723149000@kesho-kenya.org
SUMMARY:Sickle Cell Disease
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nSPEAKER PROFILES:\nDr Miguel R. Abboud\nMiguel R. Abboud earned his medical degree and then pediatrics training at the American University of Beirut\, Lebanon (1984). He completed his hematology-oncology specialty training at the Memorial Sloan-Kettering Cancer Center and The New York Hospital\, Cornell University Medical Center\, New York\, NY\, USA (1987). He was professor at Medical University of South Carolina until in August 2002\, he became the first Medical Director of the Children’s Cancer Center of Lebanon (CCCL) at the American University of Beirut Medical Center in Lebanon and Professor of Pediatrics at AUB. He established highly visible and successful bone marrow transplant\, limb salvage surgery\, and sickle cell disease programs as well as an acute lymphoblastic leukemia research protocol in collaboration with the Leukemia/Lymphoma Division at St. Jude Children’s Research Hospital in Memphis\, TN\, USA. In February 2011\, he was appointed as Chairman of the Department of Pediatrics and Adolescent Medicine at AUBMC and was offered tenured appointment as Professor of Pediatrics at AUB in July 2018. He was assigned as Scientific Advisor of the SCD Association of America in May 2019. He is also the chair of the Red Cell Biology Scientific Committee of the American Society of Hematology. He is consultant on multiple Sickle Cell Disease multicenter clinical trials protocol development. He has published above 170 publications in peer-reviewed journals. \nDr Abboud has been accorded numerous awards and honors. These include Physician of the Year by the National Committee for Lebanese Children in 2007\, a “Miracle Maker” award from A.H. Robbins in 1995\, and the Mitchell Rubin Research Award in Pediatrics in 1993\, among others. \nDr Doreen Mutua\nDoreen Mutua is a pediatrician whose passion for children with blood disorders and cancer was ignited during her residency training at the University of Nairobi where she noticed that most of these children had dismal outcomes due to late presentation\, lack of appropriate diagnostic and treatment facilities. \nDr. Mutua is a beneficiary of a two year training program conducted as a twinning program between Jimma University (Ethiopia) and ASLAN Project (a USA based Non- Governmental organization) that seeks to build capacity of   low and middle income countries in treating children with blood disorders and cancer. \nShe completed her training in May 2018 and returned back to Kenya to establish hematology/oncology services that include centers of excellence for pediatric cancer care and comprehensive sickle cell care at the Gertrude’s Children’s Hospital. \nShe is passionate about raising awareness on childhood cancer with regard to early detection\, establishing treatment guidelines and improving outcomes of Kenyan children who have cancer. She is also keen on seeing the establishment of comprehensive sickle cell centers in the country which can help reduce the morbidity and mortality of these patients. \nDr Anne Mwirigi\nAnne Mwirigi is an Assistant Professor and Consultant Haematologist working at the Aga Khan University Hospital in Nairobi\, Kenya. She obtained her undergraduate MBChB from the University of Glasgow in 2002. After her house jobs and a medical rotation in Glasgow\, she moved to London in February 2007. \nHer career in Haematology began as a senior house officer at King’s College Hospital\, following which she was accepted on the Guy’s and St Thomas’ NHS Trust Specialist Registrar Rotation in 2009. She obtained her certificate of completion of training in 2014\, and thereafter took on consultant haematologist positions for a period of two and a half years at both Guy’s and St Thomas’ and King’s College Hospitals. \nDr Mwirigi has a passion for haematology and always planned to practice haematology in her country of birth\, Kenya. Since moving back in December 2016\, she has engaged with haematopathologists and clinical haematologists in the region\, and is involved collaborative ventures aimed at improving the quality of haematology services in Kenya. She was a key member of the scientific committee which organised the Haematology and Oncology Society of Africa 3rdinaugural conference held in Nairobi in August 2017. \nDr Sarah Muma\nSarah Muma is a Pediatric Hemato – Oncologist at Kenyatta National Hospital. \nShe is a graduate of the University of Nairobi where she received her Bachelor’s degree (MBChB) as well as her Master’s degree in Pediatrics and Child Health. Dr Muma did a fellowship in Pediatric Oncology at Frere Hospital\, Walter Sisulu University in East London\, South Africa. She also holds a Master’s degree in Advanced Oncology from Ulm University in Germany. Her main interest is in developing low-cost\, high impact models of management for children with cancer in low-income settings. \nDr Rohini Radia\nRohini Radia completed her medical degree and postgraduate sub-specialty training in the UK. She obtained her MBChB degree in 1999. She continued with postgraduate training and obtained the MRCP (UK) qualification in internal medicine in 2005. She was a Specialist Registrar in haematology on a 5 year training programme at University Hospitals Bristol NHS Trust and obtained FRCPath(Haem) in 2005. \nDuring her haematology training and work as a consultant\, she pursued an interest in malignant haematology and allogeneic transplantation. She has extensive experience in haematology with a special interest in myeloid malignancies and bone marrow transplantation\, including 10 years at consultant level at The Russell Centre for Clinical Haematology\, Nottingham University Hospitals NHS Trust. Dr Radia is a Kenyan and is keen to contribute her clinical expertise where there is a huge unmet clinical need in the area of stem cell transplantation. In January 2023\, she returned home and started as BMT Consultant at the The Nairobi West Hospital. She is currently based at the Aga Khan University Hospital. \nHer BMT experience spans all aspects of stem cell transplantation from patient and donor selection to appropriate selection of conditioning protocol\, GVHD prophylaxis and post-transplant management of immune suppression\, acute and chronic GVHD and late effects. She worked closely with the Anthony Nolan transplant registry. She was the lead consultant for myelodysplasia\, GVHD and apheresis. Dr Radia carried out the first syngeneic stem cell transplant at Nottingham University Hospitals NHS Trust. Clinical research has been an interest she has consolidated by active participation in clinical trials. \nDr Grace Mbatia\nGrace Mbatia is currently serving as Full-time faculty at the Aga Khan University\, Nairobi providing clinical care to children with blood and cancer disorders as well as supporting paediatric post-graduate medical training for future paediatricians. Her core clinical interests lie in providing care to children with brain and solid tumors whereas her broader interests include supporting medical education\, health-systems research and the optimization of both general paediatric and paediatric blood and cancer care in resource-constrained settings. \nDr Catherine Muendo\nCatherine Muendo is a Paediatric Hematologist and Oncologist who completed her fellowship training at Makerere university in collaboration with Mulago National Referral Hospital\, Baylor college of medicine and Texas cancer children’s hospital. \nShe works as a consultant paediatrician at Kenyatta National Hospital. Dr Muendo received her medical degree (MBChB) and pediatrics and child health degree (MMed) at the University of Nairobi. \nShe is enthusiastic about improving the outcomes of children with blood and cancer disorders in Kenya through novel interventions that are sustainable in a resource limited setting. \nDr Irene Nzamu (Moderator)\nIrene Nzamu is a Pediatric Hematologist Oncologist. She is the Head of the Pediatric Hemato Oncology Unit at the Kenyatta National Hospital. \nDr Nzamu attained her undergraduate training (MBChB) & postgraduate training (M.MED) at The University of Nairobi. She did her Fellowship in Pediatric Hematology & Oncology at Makerere University in collaboration with Baylor College of Medicine & Global HOPE Texas Children’s Hospital. \nShe is passionate about offering evidence based\, affordable care for children with cancer & blood diseases in our resource limited settings.[/vc_column_text][vc_video link=”” title=”Webinar Recording”][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/sickle-cell-disease/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/07/sickle-cell.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240725T190000
DTEND;TZID=Africa/Nairobi:20240725T203000
DTSTAMP:20260424T005615
CREATED:20240829T083615Z
LAST-MODIFIED:20250622T144125Z
UID:9940-1721934000-1721939400@kesho-kenya.org
SUMMARY:Management of Esophageal Cancer
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nSPEAKER PROFILES:\nDr Primus Ocieng\nPrimus Ochieng is the Programme Director of MMed Radiation Oncology training at the University of Nairobi. He is both a lecturer and a consultant clinical oncologist at Kenyatta National Hospital. \nHe has keen interest in Head and neck\, prostate cancer treatment. Dr. Ochieng is committed to ensure the program produce well qualified oncologists who will make a difference in cancer treatment in the region. To achieve this\, he is keen in collaborating with various centers in the developed world in areas of training\, research and skill development. \nDr Omondi Ogude\nOmondi Ogude is a medical oncologist serving as a director of the Sandton Oncology Medical Group and practices at the Sandton Oncology Centre. Dr. Ogude received his medical degree in 2005 from the University of the Witwatersrand. He subsequently completed his Internal Medicine specialisation in 2011 and a medical oncology fellowship in 2014 at the same institution. \nDr. Ogude specialises in Lung\, Breast\, Gastrointestinal\, and Gynecological malignancies and is actively involved in research. He serves as a principal investigator and sub-investigator on multiple trials. He also chairs and sits on various multidisciplinary forums in Johannesburg and advisory boards locally and internationally. \nHe is dedicated to advocacy work in oncology\, serving as a director and board member of Campaigning For Cancer and The Johnson Rose Cancer Foundation\, both non-profit organisations that promote better cancer care and awareness in South Africa. \nHe is an active member of the South African Oncology Consortium\, European Society of Medical Oncology\, and American Society of Clinical Oncology. \nDr Cathy Samo \nCathy Samo is a general pathologist at Coast General Teaching & Referral Hospital. Her main areas of interest include anatomic pathology\, hematopathology and forensic pathology. \nDr Noordin Bashir (Moderator)\nNoordin Bashir Somo is a consultant Clinical Oncologist working at Defense Forces Memorial Hospital\, Nairobi.He  has a Master’s degree in Clinical Oncology and Nuclear Medicine from Alexandria University\, Egypt. \nHe is a member of Kenya Society of Hematology and Oncology (KESHO)\, American Society of Clinical Oncologist (ASCO) and the European Society of Medical Oncologists (ESMO). \nHis areas of interest include breast cancer\, lung cancer\, gastrointestinal cancers\, CNS\, gynecological and genitourinary cancers.[/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/management-of-esophageal-cancer/
LOCATION:Virtual Event (Zoom)\, Kenya
CATEGORIES:CME 2024,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/08/Management-of-Esophageal-Cancer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240719T190000
DTEND;TZID=Africa/Nairobi:20240719T203000
DTSTAMP:20260424T005615
CREATED:20240704T133810Z
LAST-MODIFIED:20250622T144125Z
UID:9886-1721415600-1721421000@kesho-kenya.org
SUMMARY:Meet the Expert Dinner
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nEXPERT PROFILES:\nProfessor David Carbone\nDavid Carbone is Professor of Internal Medicine\, Director of the James Thoracic Oncology Center at the OSUMC and holds the Barbara J. Bonner Chair in Lung Research. He graduated summa cum laude from Amherst College in 1977 and received an MD and PhD in Molecular Biology and Genetics at Johns Hopkins University in 1985. He then did an Internal Medicine internship and residency at Johns Hopkins Hospital through 1988 followed by a Medical Oncology fellowship \nat the National Cancer Institute in Bethesda\, MD. At Vanderbilt he was Professor of Medicine\, Cell Biology\, and Cancer Biology\, and Director of the Thoracic/Head and Neck Cancer Program\, Director and Principal Investigator of the Vanderbilt Specialized Program of Research Excellence (SPORE) in Lung Cancer for 11 years and PI of the Strategic Partnering to Evaluate Cancer Signatures (SPECS) in Lung Cancer UO1 consortium. He was recruited to The Ohio State University in 2012 to direct the James Thoracic Oncology Center. \nHis research interests\, grant support and publications have been focused on lung cancer\, and specifically lung cancer genetics\, cancer immunotherapy\, tumor-associated immunosuppression mechanisms. He has over 300+ peer-reviewed publications\, books and review articles\, has served on several NCI grant review panels\, including the clinical program project parent committee\, \nand has continuous NCI funding since early in his career. He has served on the Board of Scientific Counselors for the NCI and as Chair of the Lung Biology subcommittee for the Eastern Cooperative Oncology Group. His a Past President of the International Association for the Study of Lung Cancer (IASLC) and currently co-chair of the NCI/CTEP Thoracic Malignancy Steering Committee. \nDr Manel Haj Mansour\nManel Haj is a Consultant Medical Oncologist and Section Head of Medical Oncology at Aga Khan University Hospital\, Nairobi. She is also the current Fellowship Program Director in The Department of Hematology Oncology. \nShe graduated from the University Tunis\, and undertook her Core Internal Medicine and Medical Oncology training the most prestigious University Hospitals in Tunisia where she received her certificate of completion in 2017. She has also received part of training at the Gustave Roussy Institute of cancer treatment in Paris\, France. \nShe has previously worked as consultant medical oncologist and lecturer at Abdurrahman Mami University Hospital\, Tunisia and at a leading health care facility in Nairobi.\nDr Haj is passionate about increasing cancer awareness and promoting screening and early detection. She has also a special interest in precision oncology and clinical research and is currently investigator in several clinical trials in the Cancer Research Unit at Aga Khan University Hospital. \nShe is a member of American (ASCO)\, European (ESMO) \,Tunisian and Kenyan societies of medical oncology ((STOM  and KESHO). \nDr Allan Njau\nAllan Njau is an Assistant Professor in the department of Pathology and Laboratory Medicine at the Aga Khan University Hospital. He holds a bachelor’s degree in medicine and surgery from the University of Nairobi (2008)\, Master of medicine in Anatomic Pathology from the Aga Khan University (2016) and a fellowship in Molecular Pathology from Augusta University\, GA\, USA (2020). His interests are in the fields of precision medicine\, molecular assays especially for oncology and has a vibrant research agenda in the areas of lung cancer\, pathology informatics\, endometrial carcinoma\, extrapulmonary tuberculosis\, Covid-19\, gastric cancer and Helicobacter pylori infections. \nDr Njau is dynamic at adopting and developing molecular testing programs and is a proponent of building local capacity for precision medicine oncology. He is a member of the Association for Molecular Pathology and American Association of Cancer Research. \nWebinar Recording\n[vc_video link=”https://vimeo.com/988401622 “][/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/meet-the-expert-dinner/
LOCATION:Virtual Event (Zoom)\, Kenya
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
ATTACH;FMTTYPE=image/png:https://kesho-kenya.org/wp-content/uploads/2024/07/Lung-Cancer-scaled.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240718T190000
DTEND;TZID=Africa/Nairobi:20240718T203000
DTSTAMP:20260424T005615
CREATED:20240704T120114Z
LAST-MODIFIED:20240731T182937Z
UID:9859-1721329200-1721334600@kesho-kenya.org
SUMMARY:Osteogenic Sarcoma
DESCRIPTION:[vc_row][vc_column][vc_column_text] \n\n\n\n\n\n\n\n\nSPEAKER PROFILES:\nDr Angela McLigeyo\nAngela McLigeyo is a licensed Physician and Medical Oncologist practicing in Kenya. She has a Master of Medicine in Internal Medicine from the University of Nairobi\, a M.Sc. in Clinical Oncology from Ulm University (Germany)\, and a Fellowship in Medical Oncology from the University of Nairobi. In addition\, she obtained a 5-year board certification in Medical Oncology from ESMO in 2019. She has over 17 years of experiences in hospital and clinical settings. \nShe is a member of the Kenya Society of Haematology and Oncology (KESHO)\, European Society of Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO). She is also a fellow of the East\, Central and Southern Africa College of Physicians. \nHer core skills are in clinical decision making in internal medicine and oncology\, conducting trainings\, streamlining medical education and conducting research as well as participation in the development of treatment guidelines and protocols. \nDr McLigeyo currently provides comprehensive oncology healthcare at both public and private health facilities\, conducts research in oncology and internal medicine when opportunities arise\, and is engaged in teaching internal medicine and oncology at the Kenyatta University. She has authored several research articles in peer reviewed journals and presented abstracts at several conferences. \nProfessor Parmenas Oroko\nParmenas Kibagendi Oroko is a distinguished orthopaedic surgeon and Clinical Associate Professor at Aga Khan University Hospital Nairobi. He is also the current chairman of the Kenya Orthopaedic Association. He holds an impressive array of qualifications including MBChB\, M.Med (Surgery)\, FRCS (Ed)\, FRCSEd (Tr & Orth)\, and FRCS Eng (Tr & Orth). Specializing in lower limb arthroplasty\, pelvic and acetabular reconstruction\, as well as knee and shoulder arthroscopic surgery\, Prof. Oroko has established himself as a leading expert in his field. \nProf Oroko’s professional journey began in 1986 as a tutorial fellow at the University of Nairobi. His dedication to orthopaedics took him to the UK where he trained and worked as a consultant orthopaedic surgeon\, specializing in lower limb arthroplasty. Upon returning to Kenya in 2011\, he continued his practice and introduced advanced surgical techniques at Aga Khan University Hospital. \nHe is heavily involved in training and mentoring residents\, aiming to improve orthopaedic practice in the region. Prof Oroko’s academic contributions include extensive teaching at the University of Nairobi and Aga Khan University\, supervision of dissertation research\, and numerous publications in peer-reviewed journals. \nAdditionally\, Prof Oroko has played significant roles in administrative capacities\, including leading the expansion of orthopaedic services and contributing to reorganization efforts within the Lanarkshire Health Board in the UK. His research focuses on orthopaedic trauma and arthroplasty\, with his work presented at various local and international conferences. \nProf Oroko’s vision is to develop a center of excellence in orthopaedics in East Africa\, providing top-quality services and training future specialists in the region. \nDr Rogers Mongare (Moderator)\nRogers Mongare is a Clinical and Radiation Oncologist at the Cancer Treatment Centre\, Kenyatta National Hospital (KNH) with special interest in Head & Neck\, GIT\, Sarcomas\, Urological\, Breast and Gynaecological malignancies. He conducts clinical practice and clinical teaching at the largest referral hospital in the region. \nHe is an honorary lecturer in Radiation Oncology at the Department of Diagnostic Imaging and Radiation Medicine\, University of Nairobi. He is an active participant at the KNH multidisciplinary tumour boards working closely with other specialists in patient care. He is keen on research\, evidence based medicine and passionate on ways of improving treatment outcomes in patients using systemic and radiation treatments. He is an astute specialist oncologist who enjoys the technicalities of planning treatment\, using advanced and conventional radiation techniques with computers to deliver treatment. He participates in the technical working groups responsible for developing institutional and national radiotherapy protocols. Besides\, he never misses his weekend cross country runs. \nWebinar Recording\n[vc_video link=”https://vimeo.com/986680651″]\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n[/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/osteogenic-sarcoma/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/07/Osteogenic-Sarcoma.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240711T190000
DTEND;TZID=Africa/Nairobi:20240711T203000
DTSTAMP:20260424T005615
CREATED:20240606T084036Z
LAST-MODIFIED:20240731T182527Z
UID:9792-1720724400-1720729800@kesho-kenya.org
SUMMARY:Prostate Cancer
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nWebinar Recording\n[vc_video link=”https://vimeo.com/982788827″][/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/prostate-cancer-3/
CATEGORIES:CME 2024,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240622T070000
DTEND;TZID=Africa/Nairobi:20240622T203000
DTSTAMP:20260424T005615
CREATED:20240606T083949Z
LAST-MODIFIED:20240731T191227Z
UID:9790-1719039600-1719088200@kesho-kenya.org
SUMMARY:EA Oncology Summit
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nWebinar Recording\n[vc_video link=”https://vimeo.com/970162437″][/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/ea-oncology-summit/
CATEGORIES:CME 2024,Conferences,Continuing Medical Education (CME),Symposia and Workshops
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240613T190000
DTEND;TZID=Africa/Nairobi:20240613T203000
DTSTAMP:20260424T005615
CREATED:20240606T083849Z
LAST-MODIFIED:20240731T181046Z
UID:9788-1718305200-1718310600@kesho-kenya.org
SUMMARY:Head and Neck Cancer
DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES:[/vc_column_text][vc_column_text]Dr Njoki Njiraini\nNjoki Njiraini is a Consultant Clinical Oncologist based at the Kenyatta National Hospital. \nShe has been key in instituting multidisciplinary meetings\, problem oriented research in the department\, and streamlining patient care within the oncology clinics in the public and private sector. \nDr Njiraini holds a Bachelor’s Degree in Medicine and Surgery from the University of Nairobi\, a Master’s Degree in Radiation Oncology from the University of Cape Town\, is a Fellow of the College of Radiation Oncology (FCRO) South Africa and a graduate of the Harvard POETIC Fellowship programme. \nDr Muhammad Suhail Anwar \nMuhammad Suhail Anwar is a Consultant Medical Oncologist at the King Faisal Specialist Hospital & Research Centre and Adjunct Assistant Professor in Medical Oncology at Al Faisal University in Riyadh\, Saudi Arabia. He holds several prestigious qualifications\, including FRCR and MRCP from renowned institutions in the UK and Ireland. Dr. Anwar has been actively involved in the medical field since obtaining his MBBS degree in 1989. \nThroughout his career\, Dr. Anwar has been dedicated to research and education\, mentoring fellows\, residents\, and medical students. He has authored numerous publications and presented his work at various national and international conferences. Dr. Anwar’s research interests include breast and gynecological cancers\, and he has been involved in several clinical trials.\nHe is a member of the several professional bodies:\n•              Classification and Registration with Saudi Health Council (SCFHS)\n•              Member of the Royal College of Physicians (UK)\n•              Fellow of the Royal College of Radiologists (UK)\n•              Member of the Royal College of Physicians (IRELAND)\n•              Former Member British Gynaecological Cancer Society (UK) \nDr Primus Ochieng (Moderator)\nPrimus Ochieng is the Programme Director of MMed Radiation Oncology training at the University of Nairobi. He is both a lecturer and a consultant clinical oncologist at Kenyatta National Hospital. \nHe has keen interest in Head and neck\, prostate cancer treatment. Dr. Ochieng is committed to ensure the program produce well qualified oncologists who will make a difference in cancer treatment in the region. To achieve this\, he is keen in collaborating with various centers in the developed world in areas of training\, research and skill development. \nWebinar Recording\n[vc_video link=”https://vimeo.com/957950625 “][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/head-and-neck-cancer-4/
CATEGORIES:CME 2024,Conferences,Continuing Medical Education (CME),Symposia and Workshops
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/06/Head-and-Neck-Cancer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240606T070000
DTEND;TZID=Africa/Nairobi:20240606T203000
DTSTAMP:20260424T005615
CREATED:20240606T083750Z
LAST-MODIFIED:20240613T192457Z
UID:9786-1717657200-1717705800@kesho-kenya.org
SUMMARY:Survivorship/Palliative Care
DESCRIPTION:[vc_row][vc_column][vc_column_text]Dr Zipporah Ali \nZipporah Ali is a Palliative Care Physician and a Public Health Specialist and is the currently an independent consultant.  She serves on the boards of Kenya Hospices and Palliative Care Association (KEHPCA) and the African Palliative Care Association (APCA). She is the recent past chair of the NCD Alliance Kenya (NCDAK) and the past Vice President of Africa Organization for Research & Training in Cancer (AORTIC) East Africa. \nDr Ali was the Executive Director of Kenya Hospices and Palliative Care Association (KEHPCA)\, a position she held for 14 years before she retired in 2021. She also worked in the first hospice in Kenya-Nairobi Hospice as the Senior Medical Officer for over 14 years before she left to set up KEHPCA. In her retirement\, she continues to be involved in advocacy and creating awareness on NCDS including cancer. She has received a number of awards for her work in palliative care nationally\, regionally and globally. These include: \n\nEuropean Association for Palliative Care (EAPC) Palliative Care Leadership Award 2023\nDoctor of Law Honoris Causa-University of Dundee (2018) in recognition for her work in palliative care regionally and globally\nInternational Humanitarian Award-Women4Africa (2018)\nSocial Impact Award for the Sub-Saharan Africa region-British Council (2018)\nHonorary Doctor of the University by Oxford Brookes University (2012)\nIndividual Advocacy Award by the African Palliative Care Association and Open Society Foundations (2013\n\nDr Joyfrida Chepchumba\nJoyfrida Chepchumba is a pharmacist working with the Ministry of Health\, Kenya for over 10 years in the public health system. She holds a Master’s degree in Health Economics and Policy and a Bachelor Degree in Pharmacy both from the University of Nairobi. She is currently the Program Officer in charge of Treatment\, Palliative Care\, and Survivorship Pillar at the National Cancer Control Program. She coordinates all activities pertaining to cancer treatment\, including partnering with health experts in both public and private sector to develop policies and guidelines to inform best practice in cancer treatment. She has coordinated development of several health policies related to cancer management including the first Kenyan Palliative Care Policy\, the National Radiotherapy protocols and Rehabilitation guidelines for children with cancer. She also oversees the M-saratani mobile platform\, an e-learning platform which hosts content on early diagnosis of cancer targeting primary healthcare workers in the country. \nShe has submitted abstracts to different local and international conferences including the World Cancer Congress (2022)\, Kenya Society of Hematology and Oncology (2022)\, Oncology Nurses Chapter (2022) PSK (2015). \nShe is passionate about collaborations in developing robust heath systems to improve the quality of life for patients in the oncology space. \nDr Deborah Omeddo\nDeborah Omeddo is a Paediatric Haematologist and Oncologist working in Kisii Teaching and Referral Hospital. \nShe holds a Master’s in Paediatrics and Child Health from the University of Nairobi. She did her fellowship training at Makerere University. \nDr Omeddo strives to provide quality health services to children living with cancer and blood diseases. Her vision is that all children in Kenya will have access to quality healthcare services regardless of location and socio-economic status. \nDr Pavanraj Chana\nPavanraj Singh Chana is a Kenyan board-certified Medical Officer. His aspirations for pursuing medicine started as a childhood/paediatric cancer survivor treated for advanced head and neck embryonal rhabdomyosarcoma. Despite collateral damage and several drawbacks\, he completed his schooling in Nairobi\, obtained his medical degree in 2021 at Moi University in Eldoret and completed his medical internship in PCEA Kikuyu Mission Hospital. He has been keen to advance in clinical care\, education and research since he was a medical student by working with the International Cancer Institute\, and with the Aga Khan University Hospital Clinical Research Unit as a Medical Officer. Within and beyond these capacities\, he has been involved in a number of activities including compiling education material\, conducting education sessions\, developing audio-visual publications\, leading support groups\, engaging in screening and clinical work\, contributing to multi-disciplinary research work and been part of several clinical trial programs. He has also been supporting the Secretariat and Chairperson/President in administrative/coordinating tasks and the development of the East Central & Southern Africa College of Oncologists (ECSACO). \nDr. Chana distinguished himself early as a Medical Student and Doctor. He has presented Research work at several Conferences and is active in several Community Outreach activities. As an international and local executive member of the Beyond Sciences Initiative (BSI)\, he has helped initiate and implement a mentorship program for vulnearable populations including street youth and refugees\, developed drug adherence programs\, delivered health education and motivational talks in various forums. He has also been focused on developing evidence-based innovative solutions to medical challenges. He is ambitious to use these qualities in his aspirations to pursue residency in Internal Medicine and a fellowship in Medical Oncology and Hematology to eventually serve populations in sub-Saharan Africa. \nMs Benda Kithaka (Moderator)\nBenda Kithaka is a Health Advocacy & Behaviour Change Communications Specialist\, with over 20 years’ experience in communications\, research\, and health advocacy. \nShe is the founder of KILELE Health Association\, a Kenyan non-profit organization located in Nairobi\, with a mandate to operate in the country’s 47 Counties. \nKILELE Health specializes in empowering people living with chronic conditions (cancer and other NCDs) and their caregivers to use their lived experiences as advocacy tools for disease prevention\, stigma reduction and improvement of quality of life beyond the diagnosis.  The organization is committed to engaging members and other stakeholders in improving the understanding of quality of life issues. Current programmes focus on advocacy\, behaviour change communications\, capacity building\, and exchange of best practice\, research\, and resourcing. This is achieved through promotion of physical activity\, mental wellness\, financial wellness and pursuit of optimal health; as tools for the attainment of wellbeing. \nBenda sits on various global\, regional and local Technical Working Groups in an advocacy and advisory role. She co-chairs the AORTIC Advocacy Special Interest Group regionally in Africa\, and in Kenya is Co-Chair of the STOP Cervical Cancer technical working group. She is also a Trainer\, Facilitator and Public Speaker in advocacy for Women’s Health. Previously she served on the Board of Women4Cancer for nine years\, a Kenyan NGO she co-founded in 2012\, whose Vision is a Cervical Cancer Free Kenya. \nShe has received various awards including the International Gynecologic Cancer Society (IGCS) Distinguished Advocacy Award 2019\, the Union for International Cancer Control (UICC) award to participate as the civil society voice in the Regional Consultation on the Elimination of Cervical Cancer in the African Region (May 2019). She is also the Cancer Ambassador of the Year 2016 in Kenya. \nAn alumni of the AORTIC Master Cancer Advocacy Trainer Programme in 2013\, her advocacy work includes writing the WHO Regional Office for Africa Advocacy for Cervical Cancer Prevention and Control in Africa Facilitator Manual in 2015 – 2017\, and Master Training of Expert Trainers of Trainers from 10 WHO AFRO Countries in use of the toolkit in Africa (2017). \nTo complement her advocacy with systems strengthening\, she undertook an Executive Diploma in Leading High Performing Healthcare Organisations Program (LeHHO) at the Strathmore Business School: Institute of Healthcare Management in Kenya (2016). In 2020\, she was also trained as a MOTH Story Teller\, a skill she is using to inspire others to tell their stories in advocacy\, acting as a catalyst for change. \nUnder the KILELE Challenge\, Benda summited Mt. Kenya Climb with Cancer Survivors in September 2020\, to highlight cancer survivorship challenges and advocate for post treatment empowerment of women cancer survivors across Sub-Sahara Africa. \nWebinar Recording\n[vc_video link=”https://vimeo.com/834531312″][/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/survivorship-palliative-care/
CATEGORIES:CME 2024,Conferences,Continuing Medical Education (CME),Symposia and Workshops
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/06/Survivor-cancer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240523T190000
DTEND;TZID=Africa/Nairobi:20240523T203000
DTSTAMP:20260424T005615
CREATED:20240508T112955Z
LAST-MODIFIED:20240613T185038Z
UID:9678-1716490800-1716496200@kesho-kenya.org
SUMMARY:Melanoma
DESCRIPTION:[vc_row][vc_column][vc_column_text]SPEAKER PROFILES:[/vc_column_text][vc_column_text]Professor Nicholas Othieno-Abinya \nNicholas Anthony Othieno-Abinya is a Consultant Medical Oncologist at the Nairobi Hospital Cancer Centre. He was formerly Professor of Medicine at the University of Nairobi\, Kenya\, where he was the director of Medical Oncology Fellowship Program and also the head of Haematology/Oncology at the University of Nairobi and Kenyatta National Hospital\, Nairobi. In 2009 and 2010 he was Head of Oncology at Aga Khan University Hospital\, Nairobi. \nHe holds a Master’s degree in Internal Medicine of the University of Nairobi\, completed fellowship in Medical Oncology at the Royal London Hospital (University of London) in 1992\, and is a Fellow of the Royal College of Physicians of Edinburgh. \nHis research interests are in malignant haematology and breast cancer\, in which he has published widely in peer-reviewed journals. He also has keen interest in molecular oncology. He has also authored a text book titled Drug Treatment of Haematologic Neoplasms. He has also co-authored cancer booklets\, and has written chapters in several books. His latest book titled ‘Shadow in Perpetuity’ by Lambert Publishers was released in December 2019. \nDr. Othieno-Abinya is a member of American Society of Clinical Oncology (ASCO)\, and served in its International Affairs Committee from 2010-2012; Africa Organization for Research and Training in Cancer (AORTIC)\, having been Vice Chair for Eastern Africa and was a long time member of Council; and European Society for Medical Oncology (ESMO). He founded Kenya Society of Haematology and Oncology (KESHO)\, of which he was the first Chair\, and is still its Patron. His outstanding academic achievements were profiled in the University of Nairobi magazine\,’ Varsity Focus’ of September 2017. \nHe has received several awards and honours\, including the Kenya Breast Health Programme Award in appreciation of contribution to success of the Breast Cancer Survivors’ Conference on 11-14 July 2003; Kenya Breast Health Programme Award in recognition for outstanding contribution to the care of women with breast cancer in Kenya; Best Oral Presentation by Established Scientist Award\, 2ND KASH Conference\, Kenya Medical Research Institute\, Nairobi;  2018 Harvard Global Health Catalyst: Distinguished African Ambassador Award. \nDr Kenedy Ondede\nKenedy Ondede is a Consultant Hepatobiliopancreatic/Laparoscopic Surgeon at Kenyatta National Hospital (KNH). He is the Chief Medical Specialist at KNH. \nHis special interests include: \n\nSurgical gastroenterology\nChampion in Liver/Bariatric and Reflux surgery\n\nHe is a member of various professional membership bodies including SSK\, GSK\, HSK\, EAHPBA/IHPBA and WAALS. \nDr Ondede was awarded the Order of the Grand Warrior (OGW) for Champion Innovative Surgery 2023. \nDr Sze Wai Chan\nSze Wai Chan is a medical oncologist in private practice at Sandton Oncology\, Johannesburg\, South Africa. \nShe is the director of clinical research at Sandton Oncology and is involved as principal and sub-investigator in local and international clinical trials.  She is a member of ASCO\, ESMO\, IASLC and is an EXCO member of SASMO since 2022.  She is the vice president of the Melanoma Society South Africa (MSSA).  Her main interests are lung cancer\, melanoma\, head and neck cancer and urogenital cancer.  She has authored or co-authored in peer-reviewed journals and has presented abstracts locally and abroad. She also serves on both local and international Advisory Boards.  She was trained professionally at the University of Witwatersrand (Wits) in Johannesburg\, and she was involved previously with the Wits HREC (Human Research Ethics Committee).  She is a co-organizer in the recent SASMO/SASCETS congress (Cape Town)\, 4-7 April 2024\, and the skin cancer symposium (Cape Town)\, 1-2 March 2024. \nDr Esther Gathura (Moderator)\nDr Esther Wangui Gathura is a Senior Instructor and Consultant in Plastic and Reconstructive Surgeon\, based at the Aga Khan University Hospital in Nairobi. Her main areas of interest are in Skin Cancer Management\, Burns and Hand Surgery. She also conducts Breast Reconstruction\, Lower Limb Reconstruction and Aesthetic Surgery. \nShe attained her undergraduate qualification in Medicine (MBBS) from the University of London\, St Georges Medical School in 2008 where she qualified with multiple Merit Awards\, along with an Intercalated BSc degree in Anatomy.  Dr Gathura completed foundation medical training in the the London Deanery at the Guys and St Thomas’ Hospital following which she embarked on Core Surgical Training Yorkshire and Humber Deanery in the UK where she was first exposed to Plastic and Reconstructive Surgery at the Leeds General Infirmary. She gained the Membership of the Royal College of Surgeons qualification in 2011. Following this she then successfully applied for the competitive National Training Programme in Plastic Surgery and was placed in the East of England Deanery where she rotated in various internationally renowned Plastic Surgery Centres in the region and was exposed to various disciplines\, including Skin Cancer Management\, Head and Neck Cancer Reconstruction\, Breast Reconstruction\, Hand Surgery Burn Care and Aesthetic Surgery and Microsurgery. During this period\, she also completed a Master of Science with Merit in Burn Care. Dr Gathura gained her Fellowship of the Royal College of Surgeons Plastic and Reconstructive Surgery qualification (FRCS Plast) in 2020 and was awarded a Certificate of Completion of Training in Plastic and Reconstructive Surgery (CCT) in 2022. Following training completion\, she embarked on a Fellowship post in Paediatric Plastic Surgery at the Great Ormond Street Hospital in London. She is currently registered the General Medical Council (GMC) UK\, Specialist Register as a Plastic and Reconstructive Surgeon. \nDr Gathura always aimed to practice plastic surgery in Kenya form the outset\, and hence kept the range of her clinical experience broad and relevant to her setting.  Upon relocation back to Kenya\, she underwent a rigorous Peer review process and was subsequently registered with the Kenyan Medical Practitioners and Dentists Council (KMPDC) and attained Specialist Recognition in Plastic and Reconstructive Surgery with the KMPDC in 2023. \nDr Gathura is also widely published and has carried out multiple regional and international presentations. She is currently a member of the Education Committee of the Kenya Plastics Reconstructive and Aesthetics Surgeons (KSPRAS) and sits on the Oncology Committee within the Surgical Society of Kenya SSK. \nWebinar Recording\n[vc_video link=”https://vimeo.com/949670180 “][/vc_column_text][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/melanoma/
CATEGORIES:CME 2024,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/05/Melanoma.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240516T190000
DTEND;TZID=Africa/Nairobi:20240516T203000
DTSTAMP:20260424T005615
CREATED:20240508T112911Z
LAST-MODIFIED:20240613T183916Z
UID:9676-1715886000-1715891400@kesho-kenya.org
SUMMARY:Colorectal Cancer
DESCRIPTION:[vc_row][vc_column][vc_btn title=”Register Now” color=”danger” link=”url:https%3A%2F%2Fkesho-kenya.us2.list-manage.com%2Ftrack%2Fclick%3Fu%3Df8752eadb3a99a7b5733928d6%26id%3D1a8361e4e4%26e%3Dc11fc54911″][/vc_column][/vc_row][vc_row][vc_column][vc_tta_accordion][vc_tta_section title=”Speaker profiles” tab_id=”1715681960636-c9b066e7-5256″][vc_column_text]Dr Helena Musau\nHelena Musau is a Consultant Clinical Oncologist working at Kenyatta University Teaching Research and Referral Hospital. She is also an Adjunct Lecturer at the University of Nairobi\, Radiation Oncology program. \nDr. Musau is a Member of various Ministry of Health technical working groups aimed at improving access to cancer care in Kenya\, and the current Secretary of the Kenya Society of Haematology and Oncology (KESHO). \nDr Musau has worked in both the private and public sectors as well as managed oncology and palliative care projects at various levels over the last 13 years. \nDr Andrew Odhiambo\nAndrew Odhiambo is a Consultant Physician/Medical Oncologist & Program Director/Lecturer (Medical Oncology Fellowship Program) at the University of Nairobi. Dr. Andrew holds a Master’s degree in Internal Medicine from the University of Nairobi. He has attended preceptorship training in Haematological Oncology & Infectious Diseases from the University of Maryland Marleen & Stewart Greenbaum Cancer Centre in the United States. He later did his Fellowship in Medical Oncology in the United Kingdom and was certified by the Federation of Royal College of Physicians of the United Kingdom as well as the Association of Cancer Physicians and the European Society for Medical Oncology. He is also a Fellow of the Royal College of Physicians of Edinburgh as well as the East\, Central & Southern Africa College of Physicians. \nDr Andrew is the outgoing Secretary & former Treasurer of Kenya Society of Haematology & Oncology (KESHO). He is a member of KAP\, ASCO\, ESMO\, AORTIC & ECSACOP. Dr. Andrew serves as an expert advisor for local and international bodies i.e. MOH\, Kenya Cancer Prevention TWG\, ASCO & NCCN Cancer Treatment Guidelines Committees. He has published several articles on cancer in both international and local peer reviewed scientific journals. \nDr. Andrew was awarded the prestigious Business Daily Africa Top 40 under 40 men in the year 2017. He is passionate about cancer education and awareness especially through digital platforms. He has over 50 appearances in mainstream local and international TV and print media promoting cancer awareness. \nHis key areas of sub specialization and interest include Colon cancer\, Stomach cancer\, Breast Cancer\, Pancreatic\, Liver & Bile Duct cancer\, Cancer or Unknown Primary\, Lymphoma as well as newer treatments i.e. Immunotherapy & Targeted therapy for Colon\, Skin\, Lung\, Kidney cancers etc. For his full profile\, please visit www.drandrewodhiambo.com \nProfessor Mohsen Mokhtar\nMohsen Mokhtar is a Professor of Clinical Oncology in Al-Kasr Al-Aini Medical School and Cairo University\, Cairo Egypt. Prof Mokhtar assisted in developing the syllabus and course structure at Al-Kasr Al-Aini\, as well as\, supervised several research programs and theses. \nProf Mokhtar is the managing Director of Cairo University Center of Oncology and Nuclear Medicine NEMROCK and the President of CANSURVIVE. \nProf Mokhtar has published more than 50 articles in several regional magazines in topics including: breast\, lung\, pediatric\, colorectal\, ovarian malignancies NHL and hematologic malignancies. Professionally\, he has more than 20 years of experience in hospital management. He is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities. \nDr Allan Njau\nAllan Njau is an Assistant Professor in the department of Pathology and Laboratory Medicine at the Aga Khan University Hospital\, Nairobi\, Kenya. He holds a bachelor’s degree in Medicine and Surgery from the University of Nairobi (2008)\, Master of medicine in Anatomic Pathology from the Aga Khan University (2016) and a fellowship in Molecular Pathology from Augusta University\, GA\, USA (2020). His roles include clinical service in the Anatomic Pathology and Molecular Pathology sections of the institution as well as teaching. \nDr Njau’s  interests are in the fields of molecular assays\, especially oncology testing\, bioinformatics\, laboratory management and hepatobiliary pathology. His past and current research engagements are in the areas of pathology informatics\, Acute myeloid leukemia\, endometrial carcinoma\, extrapulmonary tuberculosis\, Covid-19\, gastric cancer and Helicobacter pylori infections. He is a member of the Association for Molecular Pathology and American Association of Cancer Research. \nDr Daniel Gathege\nDaniel Gathege is the General Surgical Unit Head and COSECSA Program Director at Kenyatta University Teaching Referral and Research Hospital. \nHe holds a Masters of Medicine in Surgery from the Aga Khan University. \nDr Gathege has an interest in addressing the increasing surgical burden and the unmet need in surgical oncology in the region. \nDr Stephen Kibengo Chege (Moderator)\nStephen Chege is a Clinical Oncologist at the Meru Teaching and Referral Hospital Oncology Center. \nHe holds a Bachelor’s Degree in Medicine and Surgery from Kampala International University\, Uganda and a Master’s in Clinical Oncology from Muhumbili University of Health and Allied Sciences\, Tanzania. \nHis areas of interest in oncology include GIT Cancers\, Head and Neck Cancers\, Prostate and Cervical Cancer. \nWebinar Recording\n[vc_video link=”https://vimeo.com/947173415″][/vc_column_text][/vc_tta_section][/vc_tta_accordion][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/colorectal-cancer/
LOCATION:Virtual Event (Zoom)\, Kenya
CATEGORIES:CME 2024,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/05/COLORECTAL-CANCER-e1715680827923.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240509T190000
DTEND;TZID=Africa/Nairobi:20240509T203000
DTSTAMP:20260424T005615
CREATED:20240508T112651Z
LAST-MODIFIED:20240613T183254Z
UID:9674-1715281200-1715286600@kesho-kenya.org
SUMMARY:Ovarian Cancer
DESCRIPTION:[vc_row][vc_column][vc_tta_accordion active_section=”1″][vc_tta_section title=”Speaker Profiles” tab_id=”1715256815421-62f7409a-d088″][vc_column_text]Dr Anisa Mburu\nAnisa Mburu is a gynecologic oncologist at the Aga Khan Hospital\, Mombasa. She is a clinical researcher with special interest in HPV-associated cancers particularly cervical cancer\, pediatric gynecological cancers and palliative care with publications and ongoing research projects on the same. \nShe graduated as a fellow and Early Career Faculty Mentor for the International Gynecologic Cancer Society (IGCS) as well as the International Cancer Institute (ICI). She completed her Editorial fellowship and has started her tenure as a reviewer for the International Journal of Gynecological Cancer (IJGC). She is also IGCS certified in the Palliative Care Program and as a Trainer of Trainers for the Preinvasive Disease Program and recently selected to be the co-chair of the Palliative Care Work group for IGCS. \nDr Anisa serves as an expert advisor for the WHO sub-committee on the Cervical Cancer Elimination Strategy through Surgical Capacity Building. She is currently on the IGCS education committee for the development of the Palliative Care curriculum and Nursing curriculum for gynecologic oncology. \nShe commenced her 2-year mentorship core with the European Society Of Gynecological Oncology and European Network of Young Gynecologic Oncologists (ESGO-ENYGO) Program under tutelage of Prof. Anna Fagotti. \nShe participated in the curriculum development and Colposcopy training of primary health care workers for the joint effort between the National Cancer Control Program (NCCP) and Clinton Health Access Initiative (CHAI). \nShe did her postgraduate (residency and fellowship) training at Moi University\, Kenya and her MBA at the University of Nicosia\, Cyprus. Her undergraduate training was at University of Nairobi\, Kenya. \nProfessor Mario Mendes Leitao\nMario Mendes Leitao is a US board certified gynecologic oncologist and a member of multiple national and international societies as well as a member of multiple national committees. He currently serves as the Director for the Minimal Access and Robotic Surgery (MARS) Program in the Department of Surgery at MSKCC which includes all of the surgical services in addition to Gynecology. \nProf Mendes is also the Director the Gynecologic Oncology Fellowship Program and a Member and Attending Surgeon in the Division of Gynecology within the Department of Surgery at MSKCC as well as a Professor in the Department of Obstetrics and Gynecology at Weill Cornell Medical College. He is on the Editorial Boards of Gynecologic Oncology and International Journal of Gynecologic Cancers. \nHe is the Section Editor for Gynecologic Oncology Section in the Annals of Surgical Oncology. He is also a member of the Oncology Special Interest Group and the Diversity and Inclusion Committee for AAGL. \nProf Mario has authored over 240 peer reviewed publications\, over 80 reviews and chapters. \nDr Sumant Gupta\nSumant Gupta is a Senior Consultant & Head Medical Oncology\, Hematology\, BMT & Director at the Metro Cancer Institute\, India. He is a renowned cancer expert and has a vast experience of treating all cancers. He trained at the Cancer Institute (WIA) Adyar\, Chennai and All India Institute of Medical Sciences (AIIMS)\nHis area of expertise includes haematological malignancies and bone marrow transplants. He has been credited for performing Faridabad’s first ever bone marrow transplant. \nHe has received many awards and recognitions including TYSA Young Scholar Award (Medical Oncologist) for the best DM – Oncology Fellow (2015). \nHe has many publications in peer reviewed national and international journals. \nHe is currently the executive committee member of the Indian Society of Oncology & Breast Cancer Foundation India. \nDr Elly Benjamin Odongo (Moderator)\nBenjamin Odongo Elly is an Obstetrician/Gynecologist and Gynaecologic Oncologist with over 23 years of experience in clinical practice and programmatic leadership of public health initiatives. He is a Senior Lecturer and Chairman of the Department of Obstetrics and Gynaecology at Kenyatta University School of Medicine. \nHe has previously served as the Head of The Department of Gynaecologic Oncology at Moi Teaching and Referral Hospital (MTRH) Eldoret/Moi University and Honorary Lecturer at Department of Obstetrics and Gynaecology\, Moi University School of Medicine. \nWebinar Recording\n[vc_video link=”https://vimeo.com/944636393 “][/vc_column_text][/vc_tta_section][/vc_tta_accordion][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/ovarian-cancer-2/
LOCATION:Virtual Event (Zoom)\, Kenya
CATEGORIES:CME 2024,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/05/unnamed-e1715258365217.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240404T190000
DTEND;TZID=Africa/Nairobi:20240404T203000
DTSTAMP:20260424T005615
CREATED:20240306T061103Z
LAST-MODIFIED:20240306T061103Z
UID:9602-1712257200-1712262600@kesho-kenya.org
SUMMARY:Non-small Cell Lung Cancer
DESCRIPTION:
URL:https://kesho-kenya.org/event/non-small-cell-lung-cancer/
CATEGORIES:CME 2024,Continuing Medical Education (CME)
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240328T190000
DTEND;TZID=Africa/Nairobi:20240328T203000
DTSTAMP:20260424T005615
CREATED:20240327T064459Z
LAST-MODIFIED:20240613T122137Z
UID:9619-1711652400-1711657800@kesho-kenya.org
SUMMARY:Management of Triple Negative Breast Cancer
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nDr Sitna Ali Mwanzi\nSitna Ali Mwanzi is a consultant medical oncologist working at the Kenyatta National Hospital in Nairobi Kenya. \nShe obtained her Bachelor of Medicine and Surgery from the University of Nairobi and Master of Medicine in Internal Medicine from the Aga Khan University Hospital\, Nairobi. She undertook a fellowship in Medical Oncology at Barts Health NHS Trust in the United Kingdom attaining a Specialist Certificate in Medical Oncology from the Royal College of Physicians and Association of Cancer Physicians in the United Kingdom. She also has a Master of Science in Advanced Oncology from Ulm University in Germany. \nHer research interests in breast cancer\, lung cancer and CML. \nDr Eric Hungu\nEric Hungu is a surgeon based at Kenyatta National Hospital\, the biggest referral hospital in East Africa. He runs a reputable breast clinic at the hospital. He undertook a one-year sub-specialty training in Breast and Endocrine Surgery at The University of Cape Town in 2017. \nHe has been involved in the drafting of National Cancer Screening Guidelines and National Cancer Treatment Protocols as an advisor to the Ministry of Health\, under the National Cancer Control Programme (NCCP). He also serves in the Surgical Society of Kenya National Council having served in various capacities since 2011. \nDr. Hungu completed his Masters training in General Surgery at The University of Nairobi in 2011. Subsequently\, he was posted to Lodwar where he worked for one year as the District Surgeon: the only surgeon between South Sudan and Eldoret. During this period\, he was on the panel of the AMREF Flying Doctors where he would carry out week long surgical outreach initiatives in the remote areas that have no access to surgeons. Hospitals he visited during this stint include Hola\, Mpeketoni\, and Mandera. \nHe was later transferred to Mama Lucy Kibaki Hospital in Kayole\, where he worked for a year before he was employed at the Kenyatta National Hospital\, as a Medical Specialist. \nHe completed his undergraduate training at the University of Nairobi in 2003\, and worked as an intern at Nyeri PGH\, prior to his posting to Maralal\, in Samburu County as a Medical Officer. \nDr. Eric is passionate in ensuring every Kenyan receives healthcare and ensures he makes a positive impact through interactions with his patients. \nProfessor Mohsen Mokhtar\nMohsen Mokhtar is a Professor of Clinical Oncology in Al-Kasr Al-Aini Medical School and Cairo University\, Cairo Egypt. Prof Mokhtar assisted in developing the syllabus and course structure at Al-Kasr Al-Aini\, as well as\, supervised several research programs and theses. \nProf Mokhtar is the managing Director of Cairo University Center of Oncology and Nuclear Medicine NEMROCK and the President of CANSURVIVE. \nProf Mokhtar has published more than 50 articles in several regional magazines in topics including: breast\, lung\, pediatric\, colorectal\, ovarian malignancies NHL and hematologic malignancies. Professionally\, he has more than 20 years of experience in hospital management. He is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities. \nDr Irene Weru (Moderator)\nIrene Weru has worked at Kenyatta National Hospital since 2003 and is current head of clinical pharmacy. \nDr. Weru holds a master’s degree in Clinical Pharmacy with sub-specialization in oncology pharmacy from the University of Nairobi. \nDr. Weru is a member of various National and international technical working groups including Demand Forecasting and Quantification TWG of the Coalition for Access to NCD Medicines\, ChemoSafe Regional TWG\, Pharmacy Advisory Council -Global HOPE Pediatric Hematology /Oncology Centers of Excellence and NCI-Kenya Quality Management Expert Working Group. \nDr. Weru is a member of several professional associations including HOPAK\, PSK\, KESHO and ISOPP. She is the current Secretary to the International Society of Oncology Pharmacy Practitioners (ISOPP). \nBesides oncology\, Dr. Weru has interest in medicines management and use especially medicine formulary management. She is also an honorary lecturer at University of Nairobi\, School of Pharmacy and provides research and clinical practice supervision to undergraduate and postgraduate students. \nWebinar Recording\n[vc_video link=”https://vimeo.com/928709973″][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/3″][/vc_column][vc_column width=”1/3″]    	\n        Register        \n        [/vc_column][vc_column width=”1/3″][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/management-of-triple-negative-breast-cancer/
CATEGORIES:CME 2024,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/03/tripple_bc.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240321T190000
DTEND;TZID=Africa/Nairobi:20240321T203000
DTSTAMP:20260424T005615
CREATED:20240319T111057Z
LAST-MODIFIED:20240613T193743Z
UID:9615-1711047600-1711053000@kesho-kenya.org
SUMMARY:Management of Multiple Myeloma
DESCRIPTION:[vc_row][vc_column][vc_column_text] \nSPEAKER PROFILES:\nDr Angela McLigeyo\nAngela McLigeyo is a licensed Physician and Medical Oncologist practicing in Kenya. She has a Master of Medicine in Internal Medicine from the University of Nairobi\, a M.Sc. in Clinical Oncology from Ulm University (Germany)\, and a Fellowship in Medical Oncology from the University of Nairobi. In addition\, she obtained a 5-year board certification in Medical Oncology from ESMO in 2019. She has over 17 years of experiences in hospital and clinical settings. \nShe is a member of the Kenya Society of Haematology and Oncology (KESHO)\, European Society of Medical Oncology (ESMO) and American Society of Clinical Oncology (ASCO). She is also a fellow of the East\, Central and Southern Africa College of Physicians. \nHer core skills are in clinical decision making in internal medicine and oncology\, conducting trainings\, streamlining medical education and conducting research as well as participation in the development of treatment guidelines and protocols. \nDr McLigeyo currently provides comprehensive oncology healthcare at both public and private health facilities\, conducts research in oncology and internal medicine when opportunities arise\, and is engaged in teaching internal medicine and oncology at the Kenyatta University. She has authored several research articles in peer reviewed journals and presented abstracts at several conferences. \nDr Peter Oyiro\nPeter Oyiro is currently a Lecturer at the Department of Clinical Medicine and Therapeutics-The University of Nairobi. He also a consultant Physician and Medical Oncologist at the Kenyatta National Hospital Teaching and Referral Hospital\, Nairobi. He attended his Research Fellowship in Hematological Malignancies at the West Virginia University Cancer Center (2013) and Medical Oncology fellowship at the University of Nairobi (2018). \nHe is a member of Kenya Society of Hematologist and Oncologist (KESHO)\, American Society of Clinical Oncologist (ASCO) and the European Society of Medical Oncologists( ESMO). \nDr. Oyiro main interest is in Research and cancer education particularly in Hematological Malignancies\, HIV associated neoplasms and Sickle cell disease as well as newer cancer targeted therapy and immunotherapy. \nDr Caroline Tonio (Moderator)\nCaroline Tonio is currently a Consultant Physician and Medical Oncologist at the Kenyatta University Teaching\, Referral and Research Hospital in Kenya. \nWebinar Recording\n[vc_video link=”https://vimeo.com/936410554″][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/3″][/vc_column][vc_column width=”1/3″][/vc_column][vc_column width=”1/3″][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/management-of-multiple-myeloma/
CATEGORIES:CME 2024,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/03/Management-of-Multiple-Myeloma.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20240307T190000
DTEND;TZID=Africa/Nairobi:20240307T203000
DTSTAMP:20260424T005615
CREATED:20240306T071440Z
LAST-MODIFIED:20240613T121447Z
UID:9604-1709838000-1709843400@kesho-kenya.org
SUMMARY:Clinical Research in Breast Cancer
DESCRIPTION:[vc_row][vc_column]    \n    	\n                	Speaker Profiles                \n        \n    \n    [vc_column_text]Professor Nicholas Othieno-Abinya \nNicholas Anthony Othieno-Abinya is a Consultant Medical Oncologist at the Nairobi Hospital Cancer Centre. He was formerly Professor of Medicine at the University of Nairobi\, Kenya\, where he was the director of Medical Oncology Fellowship Program and also the head of Haematology/Oncology at the University of Nairobi and Kenyatta National Hospital\, Nairobi. In 2009 and 2010 he was Head of Oncology at Aga Khan University Hospital\, Nairobi. \nHe holds a Master’s degree in Internal Medicine of the University of Nairobi\, completed fellowship in Medical Oncology at the Royal London Hospital (University of London) in 1992\, and is a Fellow of the Royal College of Physicians of Edinburgh. \nHis research interests are in malignant haematology and breast cancer\, in which he has published widely in peer-reviewed journals. He also has keen interest in molecular oncology. He has also authored a text book titled Drug Treatment of Haematologic Neoplasms. He has also co-authored cancer booklets\, and has written chapters in several books. His latest book titled ‘Shadow in Perpetuity’ by Lambert Publishers was released in December 2019. \nDr. Othieno-Abinya is a member of American Society of Clinical Oncology (ASCO)\, and served in its International Affairs Committee from 2010-2012; Africa Organization for Research and Training in Cancer (AORTIC)\, having been Vice Chair for Eastern Africa and was a long time member of Council; and European Society for Medical Oncology (ESMO). He founded Kenya Society of Haematology and Oncology (KESHO)\, of which he was the first Chair\, and is still its Patron. His outstanding academic achievements were profiled in the University of Nairobi magazine\,’ Varsity Focus’ of September 2017. \nHe has received several awards and honours\, including the Kenya Breast Health Programme Award in appreciation of contribution to success of the Breast Cancer Survivors’ Conference on 11-14 July 2003; Kenya Breast Health Programme Award in recognition for outstanding contribution to the care of women with breast cancer in Kenya; Best Oral Presentation by Established Scientist Award\, 2ND KASH Conference\, Kenya Medical Research Institute\, Nairobi;  2018 Harvard Global Health Catalyst: Distinguished African Ambassador Award. \nProfessor Fredrick Chite \nFredrick Chite Asirwa M.D. is the CEO of International Cancer Institute\, an organization whose main purpose is to expand Education\, Clinical Care and Training opportunities in cancer control and research across sub-Saharan Africa (SSA) through multi-sectoral collaborations and partnerships with relevant organizations both governmental and NGOs. \nHe is a Medical Oncologist & Hematologist\, PD/PI of several access to personalized cancer care and research initiatives including Blueprint Program (Kenya\, Rwanda\, Tanzania and Uganda)\, Shining Tower Program\, Clinical Trials Program-all geared towards enhancing early detection\, promoting primary HPV screening\, providing SOC diagnostics & therapeutics cancer research. He has developed several training programs including SSA Oncology Preceptorship training\, Digital Pathology Program\, Telemedicine Program\, Oncology training for Physician assistants (Clinical Officers)\, development of Oncology Nursing training program in Kenya\, Medical Oncology Fellowship Program\, Oncology Pharmacy program and assisted in the development of gynecologic oncology program. He also conducts Oncology and Hematology Clinical Trials in SSA. \nHe was previously (2011-2019)\, the Director of Academic Model Providing Access to Health Care (AMPATH Oncology & Hematology Consortium) in Kenya. In this role he developed infrastructure for telemedicine at AMPATH\, created a robust hematology & oncology outreach program in rural Kenya and participated in the development of the Kenya National Cancer Control policies\, strategic plans and guidelines by the National MOH. As PI to various clinical and research programs he established Multiple Myeloma program\, Lymphoma Program\, functional tumor registry\, Breast Cancer screening & treatment program\, Hemophilia and Sickle cell diagnostics\, treatment & research\, EMR for Oncology care and screening\, a multinational Lung Cancer Control Program\, MLCCP (Kenya\, South Africa\, Lesotho\, Tanzania\, and Eswatini). He also teaches at various Universities in SSA and participates in Scientific Review Committees (SRC) of various Oncology Clinical Trial Centers in SSA. \nDr Manel Haj Mansoor \nManel Haj is a Consultant Medical Oncologist and Section Head of Medical Oncology at Aga Khan University Hospital\, Nairobi. She is also the current Fellowship Program Director in The Department of Hematology Oncology. \nShe graduated from the University Tunis\, and undertook her Core Internal Medicine and Medical Oncology training the most prestigious University Hospitals in Tunisia where she received her certificate of completion in 2017. She has also received part of training at the Gustave Roussy Institute of cancer treatment in Paris\, France. \nShe has previously worked as consultant medical oncologist and lecturer at Abdurrahman Mami University Hospital\, Tunisia and at a leading health care facility in Nairobi. \nDr Haj is passionate about increasing cancer awareness and promoting screening and early detection. She has also a special interest in precision oncology and clinical research and is currently investigator in several clinical trials in the Cancer Research Unit at Aga Khan University Hospital. \nShe is a member of American (ASCO)\, European (ESMO) \,Tunisian and Kenyan societies of medical oncology ((STOM and KESHO). \nDr Lillian Ouma \nLilian Ouma holds a Bachelor of Medicine and Surgery (MBChB) Degree from Moi University in Eldoret\, Kenya. As a medical doctor and current head of clinical research at the International Cancer Institute\, she provides oversight on various clinical research projects. In this capacity\, she is in charge of the management of both observational and interventional research projects\, in various therapeutic fields\, ensuring all study activities are conducted according to the study protocols. In her current capacity as the research manager\, she has played a pivotal role in the establishment of research processes/systems within the research unit. \nShe is tasked with the responsibility of coordinating the execution of clinical trial protocols\, overseeing participant recruitment and retention activities\, and executing clinical quality and data quality management plans. Moreover\, she has a host of skills in a wide range of study-related activities including preparation of study protocols\, study budgets\, site preparation for study start-up activities\, study site initiation and closeout\, development of research study SOPs\, quality management plan (QMP)\, informed consent forms (ICFs)\, and case report forms (CRFs). Her extensive understanding of the principles of clinical research and applicable regulations as well as in-depth knowledge of both local and global regulatory requirements have been instrumental in her current role. \nDr Naftali Busakhala (Moderator) \nNaftali Busakhala is a Senior Lecturer and specialist Physician at Moi University and Moi Teaching and Referral Hospital. He is the departmental postgraduate coordinator at the department of pharmacology and toxicology at Moi University. He is the co-chairman of the Ampath Oncology working group. Dr Busakhala is the principal investigator of the AIDS Malignancy Consortium\, Moi University Site. He is also the principal investigator of the Lung and Breast Cancer Projects. \nHe is also a Senior Research Fellow at the Institute of Prevention and Research\, Lyon France. He has published widely in peer reviewed journals. \nDr Busakhala is the current President of the Kenya Society of Haematology and Oncology (KESHO). \nHe holds a Bachelor of Medicine and Surgery from Moi University and a Masters of Medicine in Internal Medicine from University of Nairobi. He also received post graduate training in Pharmacology  from Tianjin University China and Makerere University Uganda. He was a Fogarty trainee in Haematology and Oncology at Brown University\, USA. \nWebinar Recording\n[vc_video link=”https://vimeo.com/921757647″][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column width=”1/3″][/vc_column][vc_column width=”1/3″][/vc_column][/vc_row]
URL:https://kesho-kenya.org/event/clinical-research-in-breast-cancer-2/
CATEGORIES:CME 2024,Continuing Medical Education (CME)
ATTACH;FMTTYPE=image/jpeg:https://kesho-kenya.org/wp-content/uploads/2024/03/breast_cancer.jpg
END:VEVENT
END:VCALENDAR